Cogent Biosciences, Inc.
COGT
Kedudukan dalam Saham
#3382
Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted... Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a selective tyrosine kinase inhibitor engineered to block the KIT D816V mutation, a key driver of systemic mastocytosis, along with other KIT exon 17 mutations observed in individuals suffering from advanced gastrointestinal stromal tumors (GIST). Furthermore, Cogent holds a licensing pact with Plexxikon Inc., granting it rights for the investigation, advancement, and marketing of bezuclastinib. Previously known as Unum Therapeutics Inc., the company adopted its current name, Cogent Biosciences, Inc., in October 2020. Established in 2014, Cogent Biosciences is headquartered in Cambridge, Massachusetts.
Harga Saham
$29.64
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$5.14B
Perubahan (1 hari)
0.44%
Perubahan (1 tahun)
80.83%
Negara
US
Perdagangan Cogent Biosciences, Inc. (COGT)
Kategori
Healthcare
EPS untuk Cogent Biosciences, Inc. (COGT)
EPS setakat June 2026 TTM: $-2.31
Menurut laporan kewangan terkini dan harga saham Cogent Biosciences, Inc., EPS semasa syarikat (TTM) adalah $-2.31. Pada akhir tahun 2023, syarikat mempunyai EPS sebanyak $-2.42 peningkatan berbanding EPS tahun 2022 iaitu $-2.26.
Sejarah EPS untuk Cogent Biosciences, Inc. dari 2015 hingga 2026
EPS pada akhir setiap tahun
| Tahun | EPS | Ubah |
|---|---|---|
| 2026 (TTM) | $-2.31 | -6.10% |
| 2024 | $-2.46 | 1.65% |
| 2023 | $-2.42 | 7.08% |
| 2022 | $-2.26 | 22.16% |
| 2021 | $-1.85 | -69.17% |
| 2020 | $-6.00 | 51.13% |
| 2019 | $-3.97 | -28.47% |
| 2018 | $-5.55 | 60.87% |
| 2017 | $-3.45 | 11.29% |
| 2016 | $-3.10 | 174.34% |
| 2015 | $-1.13 | 0.00% |
EPS untuk syarikat atau pesaing yang serupa
| Syarikat | EPS | Perbezaan EPS | Negara |
|---|---|---|---|
| $17.32 | -849.78% |
US
|
|
| $-7.98 | 245.45% |
US
|
|
| $-5.29 | 129.00% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -1,300.87% |
NL
|
